Ara R, Basarir H, Ward SE. Principles of health economic evaluations of lipid-lowering strategies. Curr Opin Lipidology. 2012 Aug;23(4):271-81. doi: 10.1097/MOL.0b013e32835423d9
Pladevall-Vila M, Williams LK, Elston Lafata J, Wang M, Campbell J, Yang J, Divine G. Adherence to lipid lowering drugs is associated with ldl-cholesterol goal achievement. Poster presented at the Society for Epidemiological Research; June 2007. [abstract] Am J Epidemiol. 165(Suppl_11):S-11.
Feldman HA, Johannes CB, Araujo AB, Mohr BA, Longcope C, McKinlay JB. Low dehydroepiandrosterone and ischemic heart disease in middle-aged men: prospective results from the Massachusetts Male Aging Study. Am J Epidemiol. 2001 Jan 1;153(1):79-89.
Rosenberg L, Hennekens CH, Rosner B, Belanger C, Rothman KJ, Speizer FE. Oral-contraceptive use in relation to nonfatal myocardial infarction. Am J Epidemiol. 1980 Jan;111(1):59-66.
Rothman KJ, Fyler DC, Goldblatt A, Kreidberg MB. Exogenous hormones and other drug exposures of children with congenital heart-disease. Am J Epidemiol. 1979 Jan 1;109(4):433-9.
Rothman KJ, Fyler DC. Sex, birth order and maternal age characteristics of infants with congenital heart defects. Am J Epidemiol. 1976 Nov 1;104(5):527-34.